No change in striatal glutamate in Huntington's disease measured by proton magnetic resonance spectroscopy
β Scribed by C.E. Clarke; M. Lowry; O.W.J Quarrell
- Book ID
- 117755431
- Publisher
- Elsevier Science
- Year
- 1998
- Tongue
- English
- Weight
- 349 KB
- Volume
- 4
- Category
- Article
- ISSN
- 1353-8020
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract The gene responsible for Huntington's disease (HD) has been located, but its action and the pathophysiology of HD remain unclear. Glutamate excitotoxicity may contribute to the striatal neurodegeneration seen in HD. We used localised proton magnetic resonance spectroscopy (MRS) of the b
## Abstract Our objective was to investigate thalamic neuronal dysfunction in patients with Huntington disease (HD). We performed localized singleβvoxel proton magnetic resonance spectroscopy (MRS) of the thalamus in 22 HD patients and 25 healthy individuals. The mean age of patients was 48.5 years
## Abstract The lentiform nucleus of five patients with idiopathic Parkinson's disease (IPD) was studied by quantitative magnetic resonance spectroscopy (MRS), both before and after administration of apomorphine, and the spectra were compared with those from a group of ageβmatched normal subjects.